ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 19.0442 ↑ 0%
[as on 12 October, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option and its peers as on 12 October, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option 11.96% 0% -0.98% -4.29% -1.14% 7.13% 18.3%---
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -13.1% -0.63% -1.05% -3.92% -7.93% -13.86% 3.32% 9.38% 14.05% 13.19%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -9.27% -0.36% -1.13% -4.41% -6.43% -7.22% 6.89% 6.53% 11.91% 11.01%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 18.31% -0.09% -0.81% -5.43% -0.64% 15.21% 22.4% 17.45% 25.64% 14.35%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -3.72% -0.06% -1.75% -4.58% -7.2% -1.61% 10.83% 14.19% 18.58% 14.46%
SBI COMMA Fund - DIRECT PLAN - Growth -0.56% -0.13% -2.5% -6.68% -4.5% 3.48% 13.3% 8.38% 18.08% 13.97%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns------ -6.9% 35.22% 44.46% -9.08%

Discrete returns (monthly)

MonthDec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026
Returns -2.44% -6.81% 6.98% -4.59% 7.71% 3.1% 5.95% 4.02% 2.89% -2.83%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 2.95%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.27% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.73%

Equity

NameSymbol / ISINSectorWeight %Other links
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology12.58%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology9.23%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.72%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services4.84%
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.75%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology4.31%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology4.22%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology4.02%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.97%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology3.31%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology3.18%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology3.10%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services2.98%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.92%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services2.82%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology2.43%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology1.97%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.92%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.59%
Shilpa Medicare LimitedSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.59%
Healthcare Global Enterprises LimitedHCG (INE075I01017)Healthcare Services1.55%
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies1.50%
Aster DM Quality Care LimitedASTERDM (INE914M01019)Healthcare Services1.47%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.32%
Shaily Engineering Plastics LimitedSHAILY (INE151G01028)Consumer Durables1.25%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology1.25%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology1.15%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services1.05%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology1.02%
Linde India LimitedLINDEINDIA (INE473A01011)Chemicals & Petrochemicals0.99%
Rainbow Childrens Medicare LimitedRAINBOW (INE961O01016)Healthcare Services0.93%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.87%
Supriya Lifescience LimitedSUPRIYA (INE07RO01027)Pharmaceuticals & Biotechnology0.81%
Metropolis Healthcare LimitedMETROPOLIS (INE112L01020)Healthcare Services0.74%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology0.71%
Caplin Point Laboratories LimitedCAPLIPOINT (INE475E01026)Pharmaceuticals & Biotechnology0.61%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.60%

Debt

NameIsinRatingWeight %Yield
Portfolio data is as on date 31 August, 2026

NAV history

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
12 October, 202619.0442 0%
9 October, 202619.0438 0.65%
8 October, 202618.9208 -2.36%
7 October, 202619.3776 -0.35%
6 October, 202619.4465 1.11%
5 October, 202619.2322 -1%
1 October, 202619.4256 -0.19%
30 September, 202619.4628 -2.31%
29 September, 202619.9225 0.17%
28 September, 202619.8882 -1.05%
25 September, 202620.0995 -0.35%
24 September, 202620.1707 -0.73%
23 September, 202620.3188 0.83%
22 September, 202620.1506 -0.58%
21 September, 202620.2674 1.08%
18 September, 202620.0514 0.95%
17 September, 202619.8626 1.46%
16 September, 202619.5775 -0.15%
15 September, 202619.6063 -1.46%
11 September, 202619.8969 -0.3%
10 September, 202619.9577 -0.46%
9 September, 202620.0493 -0.25%
8 September, 202620.0994 0.83%
7 September, 202619.9341 0.41%
4 September, 202619.8534 -0.61%
3 September, 202619.9760 -0.18%
2 September, 202620.0127 -0.09%
1 September, 202620.0303 -1.26%
31 August, 202620.2852 0.89%
28 August, 202620.1064

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 19.0442 as on 12 October, 2026.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 11.96% as on 12 October, 2026.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 7.13% as on 12 October, 2026.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 18.3% as on 12 October, 2026.
  • What are top 10 holdings of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    Top 10 holdings of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are:
    • Sun Pharmaceutical Industries Limited
    • Divi's Laboratories Limited
    • Apollo Hospitals Enterprise Limited
    • Max Healthcare Institute Limited
    • Torrent Pharmaceuticals Limited
    • Dr. Reddy's Laboratories Limited
    • Cipla Limited
    • Laurus Labs Limited
    • Aurobindo Pharma Limited
    • Mankind Pharma Limited
    • Neuland Laboratories Limited
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.